|
LOC729020 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.51740000032508E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67200000406243E-08 |
| Normal-vs-Stage2 |
5.604000E-02 |
| Normal-vs-Stage3 |
6.725800E-01 |
| Normal-vs-Stage4 |
2.073800E-02 |
| Stage1-vs-Stage2 |
2.226800E-01 |
| Stage1-vs-Stage3 |
8.175900E-03 |
| Stage1-vs-Stage4 |
4.551400E-01 |
| Stage2-vs-Stage3 |
2.251000E-01 |
| Stage2-vs-Stage4 |
8.900000E-01 |
| Stage3-vs-Stage4 |
2.596400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63470000039234E-07 |
| Normal-vs-AfricanAmerican |
1.247890E-04 |
| Normal-vs-Asian |
7.353800E-01 |
| Caucasian-vs-AfricanAmerican |
6.504600E-01 |
| Caucasian-vs-Asian |
5.589200E-01 |
| AfricanAmerican-vs-Asian |
6.155600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25900000425005E-08 |
| Normal-vs-Female |
1.681840E-01 |
| Male-vs-Female |
1.581360E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.46090000000688E-05 |
| Normal-vs-Extreme_Weight |
1.86549997671648E-09 |
| Normal-vs-Obese |
4.555700E-03 |
| Normal-vs-Extreme_Obese |
1.330440E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.986630E-01 |
| Normal_Weight-vs-Obese |
2.129000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.804200E-01 |
| Extreme_Weight-vs-Obese |
3.515800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.191440E-01 |
| Obese-vs-Extreme_Obese |
8.584600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.496800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.96256999999145E-05 |
| Normal-vs-Age(61-80Yrs) |
9.31870000053792E-08 |
| Normal-vs-Age(81-100Yrs) |
4.449800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.192050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.439600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.580500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.826580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.445600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.656200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.92930004883874E-09 |
| Normal-VS-Type2 PRCC |
2.076400E-02 |
| Normal-VS-KIRP CIMP |
1.820610E-01 |
| Normal-VS-Unclassified PRCC |
5.187900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.761950E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.4368000000875E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.770250E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.463970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.666600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.648010E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.48909999994918E-06 |
| Normal-vs-N1 |
9.782600E-01 |
| Normal-vs-N2 |
8.119600E-02 |
| N0-vs-N1 |
3.335400E-03 |
| N0-vs-N2 |
6.696000E-01 |
| N1-vs-N2 |
3.857000E-01 |
|
|
